Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avadel AVDL -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (10)	4/10/2003 1:30:33 PM
From: jmanvegas	Read Replies (2) \| Respond to of 240

Nothing wrong with taking profits ever. Could see further pullback - could close the gap in the mid - high 7's. MM's may try to force it down, close out weak hands. But looking at long term charts since the company went public in mid 1996, the chart tells me that this stock, someday in the future (don't know when), will make a run to its historic high of $12.94. If the company can trade at a $280M market cap, which is reasonable in the 2005-2006 time frame based upon these new deals really bearing monetary fruit for FLML, and assuming additional new pharma deals are announced within the next 2 years. That gives us a stock price of $17+. It's not unreasonable for FLML to reach a $280 market cap IMHO someday. If the diabetes formulation Basulin is what it appears to be, then we could see our $20+. In the meantime, there may be a back filling of share price and maybe an attempt to shake the weak leaves from the tree. Good luck to you and that super trade. jman